Metir plc (AIM:MET)

Market Cap	3.10M +33.5%
Revenue (ttm)	1.44M +520.7%
Net Income	-867.00K
EPS	-0.00
Shares Out	443.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	139,348
Open	0.6600
Previous Close	0.7000
Day's Range	0.6600 - 0.6600
52-Week Range	0.5000 - 1.4900
Beta	0.87
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Metir

Metir plc engages in research, development, and commercialization of miniaturized mass spectrometry instruments in the United Kingdom, the United States, the European Union, China, and Qatar. It offers compact mass spectrometers under the Microsaic 4500 MiD brand; Modern Water MicroTox CTM, FX, and LX toxicity monitors; consumables and spare parts; product support services, such as training sales and service teams; and assurance warranties. The company also provides science and engineering consultancy, laboratory services, and monitoring servic...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1998
• Employees: 5
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: MET

Financial Performance

In 2025, Metir's revenue was 1.44 million, an increase of 520.69% compared to the previous year's 232,000. Losses were -867,000, -45.02% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 24, 2026

Data Sources Report a data error